Back To Schedule
Monday, September 19 • 1:30pm - 2:00pm
Presentation: Early Commercial Forecasting & Strategy (‘children are not small adults’)

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

The forecast is part of a broader exercise of gaining an in-depth qualitative understanding of a particular area, which is aimed at unlocking the Value a novel therapy can offer. Hence while in the infancy of a product budgets are typically tighter but possible product value propositions are more numerous the process has to be managed very differently. Optimize value creation for your organization and adopt a value-based approach when optimising the opportunity for patients, HCPs and payers. This presentation will describe the underlying philosophy and the basic modules required to complete an early-stage commercial assessment successfully.
  • Examine organizational value drivers behind early-stage strategy, various project archetypes and describe the differences in approach
  • Discuss the pros and cons of various forecasting methodologies and frameworks in light of different opportunities
  • Discover how helpful tools specifically designed for early-stage work can make life easier
  • Understand the differences of going through this process in a smaller biotech or in a larger pharma organization

avatar for Erik Holzinger, MBA

Erik Holzinger, MBA

Director, groupH
Erik Holzinger MBA is the founder of groupH Limited a Consulting company dedicated to optimising the value of novel treatments, commercial decision making and analysis. Erik is also active as member of the ephmra Annual Conference Organising Committee and co-founder of the ephmra... Read More →

Monday September 19, 2022 1:30pm - 2:00pm EDT